---
title: "Cue BioPharma (CUE.US) — 財務報表"
type: "Symbol"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/quote/CUE.US/norm.md"
symbol: "CUE.US"
name: "Cue BioPharma"
parent: "https://longbridge.com/zh-HK/quote/CUE.US.md"
datetime: "2026-05-19T21:44:07.819Z"
locales:
  - [en](https://longbridge.com/en/quote/CUE.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/CUE.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/CUE.US/norm.md)
---

# Cue BioPharma (CUE.US) — 財務報表

## 損益表 (USD)

| 指標 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | -1.08 | 0.4303 | -2.22 | -2.67 | -4.95 |
| ROE | -86.23% | 31.96% | -189.73% | -274.29% | -407.23% |
| 營業收入 | 5.69M | 21.94M | 2.15M | 2.95M | 421000.00 |
| 凈利潤 | -5.18M | 1.58M | -7.45M | -8.48M | -12.26M |
| 營業利潤 | -5.36M | 1.96M | -7.54M | -8.63M | -12.30M |
| 毛利率 | 100.00% | -50.80% | 80.04% | -167.77% | -1716.39% |
| 凈利率 | -91.07% | 7.22% | -346.58% | -287.14% | -2911.40% |
| 利潤含金量 | - | -181.97% | - | - | - |

## 資產負債表 (USD)

| 指標 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 資產與負債 | 30.88M | 42.21M | 31.64M | 40.71M | 22.25M |
| 權益乘數 | 1.43 | 1.60 | 2.39 | 2.24 | 3.38 |
| 每股凈資產 | 6.64 | 8.21 | 5.11 | 7.13 | 3.19 |
| 資產周轉率 | 1.23 | 0.7383 | 0.1857 | 0.1996 | 0.2097 |
| 現金及短投 | 17.44M | 28.23M | 20.42M | 27.96M | 14.05M |
| 存貨與應收 | - | - | - | - | - |
| 長期投資 | 3.61M | 4.32M | 4.91M | 5.57M | 4.11M |
| 凈債務 | -14.00M | -24.03M | -14.25M | -20.33M | -6.92M |

## 現金流量表 (USD)

| 指標 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 經營現金流 | -10.94M | -1.08M | -9.02M | -3.42M | -8.17M |
| 投資現金流 | -121000.00 | 7.02M | -6.77M | -27000.00 | -150000.00 |
| 融資現金流 | 306000.00 | 9.49M | 1000.00 | 17.80M | -1.00M |
| 自由現金流 | -8.86M | 1.23M | -9.79M | 2.59M | -3.80M |
| 現金流充裕率 | -9042.98% | -71.73% | -902.40% | -332.52% | -710.61% |
| 舉債與償債 | - | - | - | - | - |
| 資本支出 | -121000.00 | 0.0000 | 0.0000 | -27000.00 | -150000.00 |